A Statistical Approach Towards Development and Optimization of Conventional Immediate Release Tablet of Nimorazole by Wet Granulation Technique Conventional immediate release tablet of nimorazole by wet granulation technique
Iranian Journal of Pharmaceutical Sciences,
مجلد 9 عدد 4 (2013),
1 تشرين الأول 2013
,
الصفحة 23-38
https://doi.org/10.22037/ijps.v9.40856
الملخص
Till date, most of the drugs have been given in conventional immediate release dosage form. Nimorazole is an anticancer drug, used as a hypoxic radiosensitizer in patients undergoing radiotherapy and no formulation has been available in the market till now. Hence, for the purpose to develop an immediate release dosage form, a statistical optimization process has been employed to quantify the effect of two primary excipient MCC and maize starch on its immediate release characteristics. A series of combinations by varying the composition of the two excipients were prepared and their effect on tablet property such as disintegration time, hardness and friability were analyzed using statistical design software. An optimized formulation generated by the software, was evaluated for tablet properties and drug-excipient compatibility study was carried out by FT-IR analysis and DSC thermogram analysis. A SEM image of the granules was recorded to study surface morphology. A 70:50 combination of MCC and starch was found to be the best optimized formulation for an immediate release tablet without affecting its hardness and stability. Disintegration time increased with increasing amount of starch, but decreased with increasing amount of MCC. The low prediction error observed during evaluation of the final formulation indicated the high prognostic capability of the RSM methodology. FT-IR and DSC study confirmed the compatibility of the drug with excipients.
- nimorazole
- MCC
- maize starch
- disintegration time
- hardness
- friability
كيفية الاقتباس
المراجع
[2] Roy RB, Laird SM, Heasman L. Treatment of trichomoniasis in the female: A comparison of metronidazole and nimorazole. Brit. J . Vener. Dis (1975) 51: 281- 286.
[3] Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L, Lindelov B, Jorgensen K. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother. Oncol (1998) 46: 135-46.
[4] Henk JM, Bishop K, Shepherd SF. Treatment of head and neck cancer with CHART and nimorazole: phase II study. Radiother. Oncol (2003) 66: 65-70.
[5] Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HA, Kanig JL, eds. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia, PA: Lea & Febiger; (1986) 293- 345.
[6] Agarwal R, Naveen Y. Pharmaceutical Processing – A Review on Wet Granulation Technology. Int. J. Pharm. Front. Res ( 2011) 1: 65-83.
[7] Azubuike PC, Okhamafe AO, Falodun A. Some Pharmacopoeial and Diluent-Binder Properties of α-Cellulose derived from Maize Cob in Selected Tablet Formulations. J. Chem. Pharm. Res (2011) 3: 481-88.
[8] Bas B, Boyac IH. Modeling and optimization I: Usability of response surface methodology. J. Food Eng (2007) 78: 836 - 845.
[9] Vincent G, Coteron A, Martinez M, Aracil Z. Application of the factorial design of experiments and response surface methodology to optimize biodiesel production. IND. CROP. PROD (1998) 8: 29-35.
[10] Nazzal S, Khan MA. Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system. AAPS Pharm. SciTech (2002) 3(1): 1-9.
[11] The british pharmacopeia. Her Majesty’s stationary office, London: 2004.
[12] Martin A, Swarbrick J, Cammarata A. Physical pharmacy. 3rd ed. Bombay: KM Varghese Company (1991) 314–46.
[13] Martin A, Bustamante P, Chun AHC, Physical Pharmacy, 4th Ed., Indian Reprint, B.I. Waverly Pvt.Ltd., New Delhi (1994) 444.
[14] Train D. Some aspects of the property of angle of repose of powders. J Pharm Pharmacol (1958) 10: 127T-134T.
[15] K Marshall. Compression and Consolidation of Powered Solid. In: Lachman L, Lieberman HA, editors. The theory and practice of industrial pharmacy. Special Indian edition (2009) 66-99.
[16] Deshmukh RK, Naik JB. Diclofenac Sodium-Loaded Eudragit® Microspheres: Optimization Using Statistical Experimental Design. J. Pharm. Innov (2013) 8: 276–87.
[17] Nayak AK, Pal D. Development of pH-sensitive tamarind seed polysaccharide–alginate composite beads for controlled diclofenac sodium delivery using response surface methodology. Int. J. Bio. Macro (2011) 49: 784 - 93.
[18] Al haushey L, Bolzinger MA, Bordes C, Gauvrit JY, Briancon S. Improvement of a bovine serum albumin microencapsulation process by screening desing. Int. J. Pharm. (2007) 344:16–25.
[19] De Lima JBC, Coelho LF, Contiero J. TheUse of Response Surface Methodology in Optimization of Lactic Acid Production: Focus on Medium Supplementation, Temperature and pH Control. Food Technol. Biotechnol (2010) 48(2): 175–81.
[20] Damodharan N, Manimaran V, Sravanthi B. Formulation development and evaluation of delayed release doxycycline tablets. Int. J. pharm. Pharm. Sci (2010) 2(1):116-19.
[21] Korsemeyer R, Gurny RNP. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm (1983) 15:25–35.
[22] Costa P, Lobo JMS. Modeling and comparison of dissolution profile. Eur. J. Pharm. Sci (2001) 13(2):123-33.
- الملخص المشاهدات: 57 الأوقات
- IJPS_Volume 9_Issue 4_Pages 23-38 (English) التنزيلات: 28 الأوقات